Showing 1 - 20 results of 59 for search 'Tina Vilsbøll', tempo de consulta: 0.06s
Limitar resultados
-
1
-
2
Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat por David S. Mathiesen, Asger Lund, Tina Vilsbøll, Tina Vilsbøll, Tina Vilsbøll, Filip K. Knop, Filip K. Knop, Filip K. Knop, Filip K. Knop, Jonatan I. Bagger, Jonatan I. Bagger
Publicado 2021-01-01
Artigo -
3
-
4
A glucose-insulin-glucagon coupled model of the isoglycemic intravenous glucose infusion experiment por Vijaya Subramanian, Jonatan I. Bagger, Jonatan I. Bagger, Jonatan I. Bagger, Jens J. Holst, Jens J. Holst, Filip K. Knop, Filip K. Knop, Filip K. Knop, Filip K. Knop, Tina Vilsbøll, Tina Vilsbøll, Tina Vilsbøll
Publicado 2022-09-01
Artigo -
5
Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD por Marta Seghieri, Marta Seghieri, Alexander S. Christensen, Andreas Andersen, Anna Solini, Filip K. Knop, Filip K. Knop, Filip K. Knop, Tina Vilsbøll, Tina Vilsbøll
Publicado 2018-11-01
Artigo -
6
-
7
How glucagon-like peptide 1 receptor agonists work por Christine Rode Andreasen, Andreas Andersen, Filip Krag Knop, Tina Vilsbøll
Publicado 2021-07-01
Artigo -
8
Hypoglycaemia and cardiac arrhythmias in diabetes por Andreas Andersen, Peter G. Jørgensen, Filip K. Knop, Tina Vilsbøll
Publicado 2020-05-01
Artigo -
9
Accuracy of continuous glucose monitoring during exercise-related hypoglycemia in individuals with type 1 diabetes por Kaisar Maytham, Kaisar Maytham, Per G. Hagelqvist, Per G. Hagelqvist, Susanne Engberg, Julie L. Forman, Ulrik Pedersen-Bjergaard, Ulrik Pedersen-Bjergaard, Filip K. Knop, Filip K. Knop, Filip K. Knop, Tina Vilsbøll, Tina Vilsbøll, Tina Vilsbøll, Andreas Andersen, Andreas Andersen
Publicado 2024-04-01
Artigo -
10
-
11
A single dose of exenatide had no effect on blood flow velocity in the middle cerebral artery in elderly healthy volunteers: Randomized, placebo-controlled, double-blind clinical t... por Joakim Ölmestig, Joakim Ölmestig, Ida R. Marlet, Tina Vilsbøll, Tina Vilsbøll, Jørgen Rungby, Jørgen Rungby, Egill Rostrup, Kate L. Lambertsen, Kate L. Lambertsen, Kate L. Lambertsen, Christina Kruuse, Christina Kruuse
Publicado 2022-07-01
Artigo -
12
Glimepiride monotherapy versus combination of glimepiride and linagliptin therapy in patients with HNF1A-diabetes: a protocol for a randomised, double-blinded, placebo-controlled t... por Torben Hansen, Tina Vilsbøll, Filip Krag Knop, Alexander Sidelmann Christensen, Heidi Storgaard, Sofie Hædersdal
Publicado 2018-10-01
Artigo -
13
-
14
-
15
-
16
-
17
Protocol for a randomised, double-blinded, placebo-controlled, double-dummy 6-week clinical trial comparing the treatment effects of the glucagon-like peptide 1 receptor agonist li... por Tina Vilsbøll, Martin Lund Kårhus, Andreas Brønden, Julie Lyng Forman, Anne Haaber, David Peick Sonne
Publicado 2021-02-01
Artigo -
18
Is it Time to Transform Our Treatment Of Type 2 Diabetes por Michael Nauck, Dídac Mauricio, Anthony Barnett, Tina Vilsbøll, Samy Hadjadj, Peter Rossing, Edoardo Mannucci, Harald Darius, Chantal Mathieu
Publicado 2013-10-01
Artigo -
19
Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. por Heidi Storgaard, Lise L Gluud, Cathy Bennett, Magnus F Grøndahl, Mikkel B Christensen, Filip K Knop, Tina Vilsbøll
Publicado 2016-01-01
Artigo -
20